Methyl 4-[[4-(methylcarbamoyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]amino]quinazoline-8-carboxylate
C21H27N5O5 — CID 126659046
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 4-[[4-(methylcarbamoyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]amino]quinazoline-8-carboxylate
Methyl 4-[[4-(methylcarbamoyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]amino]quinazoline-8-carboxylate (PubChem CID 126659046) has the molecular formula C21H27N5O5 and a molecular weight of 429.48 g/mol. Its IUPAC name is methyl 4-[[4-(methylcarbamoyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]amino]quinazoline-8-carboxylate.
Molecular Properties
| Compound Name | Methyl 4-[[4-(methylcarbamoyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]amino]quinazoline-8-carboxylate |
|---|---|
| PubChem CID | 126659046 |
| Molecular Formula | C21H27N5O5 |
| Molecular Weight | 429.48 g/mol |
| Exact Mass | 429.20 |
| IUPAC Name | methyl 4-[[4-(methylcarbamoyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]amino]quinazoline-8-carboxylate |
| SMILES | CNC(=O)C1CN(C(=O)OC(C)(C)C)CC1Nc1ncnc2c(C(=O)OC)cccc12 |
| InChI | InChI=1S/C21H27N5O5/c1-21(2,3)31-20(29)26-9-14(18(27)22-4)15(10-26)25-17-12-7-6-8-13(19(28)30-5)16(12)23-11-24-17/h6-8,11,14-15H,9-10H2,1-5H3,(H,22,27)(H,23,24,25) |
| InChIKey | NCBFRMQPZZYXNC-UHFFFAOYSA-N |
| XLogP | 1.81 |
| TPSA | 122.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.48 |
| LogP ≤ 5 | 1.81 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126659046 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.